Market Research Reports

The nerve growth factor is a tumor tissue produced growth factor that promotes the growth and differentiation of sympathetic and sensory ganglia. It is the first growth factor to be identified. An elevated level of nerve growth factor leads to inflammation and peripheral nerve injury. The nerve growth factor is secreted in the body following stimulus (eg, chemical, thermal, or mechanical). Clinically, an elevated level of nerve growth factor in t...

The Cancer Biosimilars Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031.   Biosimilar is defined as a type of biological product that is approved by respective regulatory bodies because of its clinical similarity to already approved biological products. This is relatively cheaper than biologics. The abnormal growth of call is called cancer. Cancer is the second leading cause of death across the globe. Ma...

Global Abdominal Aorta Stent Grafts Market is expected to grow at a 4.9% CAGR during the forecast period for 2025-2034. The Aortic abdominal stent graft is used for abdominal aneurysm endovascular repair. Endovascular aneurysm repair (EVAR), is a new treatment option for abdominal aortic aneurysm in which a graft is inserted into the aorta to strengthen it. This surgery doesn’t need surgically opening the chest or abdomen and is done using...

What is Filgrastim Biosimilars Market Size? Global Filgrastim Biosimilars Market Size was valued at USD 1.22 Bn in 2025 and is predicted to reach USD 3.93 Bn by 2035 at a 12.5% CAGR during the forecast period for 2026 to 2035. Filgrastim Biosimilars Market Size, Share & Trends Analysis Report By Application (Febrile Neutropenia, Genital Neutropenia, Idiopathic Neutropenia, and Others), By Distribution Channel (Online Pha...

Prevention of progression and proliferation of infectious diseases in the body has always been the point of discussion, which has developed a throng of techniques to alter these effects of the immune system. Immunotherapy is a treatment that uses particular parts of a person’s immune organism to fight against cancer. The immune system is a collection of special cells, organs and substances which protect us from diseases and infections. Immu...

Global Bevacizumab Biosimilar Market is expected to grow at an 9.0% CAGR during the forecast period for 2025-2034. Bevacizumab is a recombinant humanized monoclonal antibody that neutralizes vascular endothelial growth factor A (VEGF-A) biologic activity (an essential endothelial cell mitogen and survival factor). It is the first anti-angiogenic therapy approved for the treatment of human cancer. The drug was developed by F. Hoffmann-La Roche AG...

TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034.  Tumor necrosis factors are a group of cytokines that are secreted by macrophages and may induce cell death of certain tumor cell lines, which leads to inflammation. TNF inhibitors are the drug that stops inflammation. They are mainly indicated for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, anklyosing Spo...

The Global Clinical Trial Services Market size is valued at USD 22.58 billion in 2023 and is predicted to reach USD 42.86 billion by the year 2031 at an 8.44% CAGR during the forecast period for 2024-2031. The services used by biopharmaceutical or pharmaceutical companies to conduct clinical trial either for the approval of a new drug or biologic or for the entry of new generic or biosimilar to the market is ...

What Deep Vein Thrombosis Market Size? Global Deep Vein Thrombosis Market Size is valued at USD 1.05 Billion in 2025 and is predicted to reach USD 1.55 Billion by the year 2035 at a 4.0 % CAGR during the forecast period for 2026 to 2035. Deep Vein Thrombosis Market Size, Share & Trends Analysis Report By Treatment (Clot Busters, Blood Thinners, Inferior Vena Cava Filters, Compression Stockings, Others), By Distribution Channe...

The Breast Cancer Market is expected to grow at an 8.8% CAGR during the forecast period for 2024-2031.  Breast cancer start when cells in the breast begin to grow out of control. These cells form tumour that can often see on an x-ray. Breast cancer is the most common cancer among women, after skin cancer and second leading cause of cancer death in women after lung cancer. Breast cancer is broadly classified into two include non-invasive and...

What is Etanercept Biosimilar Market Size? Global Etanercept Biosimilar Market Size is valued at USD XX Mn in 2025 and is predicted to reach USD XX Mn by the year 2035 at an 18.00% CAGR during the forecast period for 2026 to 2035. Etanercept Biosimilar Market Size, Share & Trends Analysis Report By Applications (Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, And Ankylosing Spondylitis), Distribut...

The Ovarian Cancer Market is expected to grow at a 10.5% CAGR during the forecast period for 2024-2031.  Ovarian cancer rank fifth in cancer deaths among women and accounting for more deaths than any other cancer of the female reproductive system. Previously it believed that cancer begin only in the ovaries, but recent evidence suggests that many ovarian cancer may start in the fallopian tubes. Factors can increase risk of cancer include ol...

The preceding decades have shown higher incidence and prevalence trends for cancer. Globally, the scenario is worsening with the mounting number of cancer patients every year. The number of new cancer cases is predicted to rise by 54% within the next two decades. In economically developing countries, adoption of western lifestyles, such as smoking, poor diet, physical inactivity, and fewer childbirths, will gradually increase the burden of the tr...

What is Fragile X Syndrome Market Size? Global Fragile X Syndrome Market Size is valued at USD 23.38 Million in 2025 and is predicted to reach USD 50.85 Million by the year 2035 at a 8.5% CAGR during the forecast period for 2026 to 2035.  Fragile X Syndrome Market Size, Share & Trends Analysis Report By Treatment (Ssris, Psychostimulants, Atypical Antipsychotics, Anticonvulsants, Antihypertensive Anxiolytics, Benzodiazepines, Lith...

What is Endometrial Ablation Systems Market Size? Endometrial Ablation Systems Market Size is valued at 3.94 Billion in 2025 and is predicted to reach 8.15 Billion by the year 2035 at a 7.9% CAGR during the forecast period for 2026 to 2035. Endometrial Ablation Systems Market Size, Share & Trends Analysis Report By Techniques (Hyper thermic ablation, Radio frequency ablation, Microwave ablation, Laser ablation, Cryoablation, Others), By End...

The Radiofrequency Ablation Catheter Market Size is valued at 4237.92 Million in 2023 and is predicted to reach 9,166.28 Million by the year 2031 at a 10.25% CAGR during the forecast period for 2024-2031.  Catheter ablation is a medical procedure that is used to treat some types of arrhythmia. Heart arrhythmia is group of condition leads to irregular heartbeat. During this procedure a long, thin, flexible tube is placed into blood...

Remote Catheter Manipulation Device Market is expected to grow at a 6.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing cases of cardiovascular conditions such as arrhythmias, coronary artery disease, and heart failure necessitate advanced catheterization procedures, boosting the demand for remote catheter manipulation devices. Minimally invasive techniques are becoming i...

Infliximab Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an XX % CAGR during the forecast period for 2025-2034. Infliximab is chimeric anti-TNF monoclonal antibody approved for the treatment of Chron’s Disease. It is also approved for the treatment of other autoimmune diseases such as Psoriasis, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and others. It is...

The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031. Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as al...

What is Adalimumab Biosimilar Market Size? Global Adalimumab Biosimilar Market Size is estimated to grow at the CAGR of 24.6% during the forecast period for 2026 to 2035. Adalimumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Amjevita, Cyltezo, Hadlima, Yusimry, Hulio, Hymiroz, Abrilada, Yuflyma, Exemptia, Adalirel, Cipleumab and other pipeline products), By Application, By Distribution Channel, By Region, And By Segm...